Promore Pharma AB (publ) undertook an 18-site clinical trial to further prove the efficacy and safety of ropocamptide (LL-37) for patients with hard to…
Our Partners
This website uses cookies to offer you a better browsing experience and analyze site traffic. Read about how we use cookies and how you can control them by clicking “Learn More“. If you continue to use this site, you consent to our use of cookies.
Read more
